Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If you need an accessible version of this item please contact JSTOR User Support

Central Line–Associated Bloodstream Infection Surveillance outside the Intensive Care Unit: A Multicenter Survey

Crystal H. Son MPH, Titus L. Daniels MD MPH, Janet A. Eagan RN MPH CIC, Michael B. Edmond MD MPH MPA, Neil O. Fishman MD, Thomas G. Fraser MD, Mini Kamboj MD, Lisa L. Maragakis MD MPH, Sapna A. Mehta MD, Trish M. Perl MD MSc, Michael S. Phillips MD, Connie S. Price MD, Thomas R. Talbot MD MPH, Stephen J. Wilson MD MPH and Kent A. Sepkowitz MD
Infection Control and Hospital Epidemiology
Vol. 33, No. 9 (September 2012), pp. 869-874
DOI: 10.1086/667378
Stable URL: http://www.jstor.org/stable/10.1086/667378
Page Count: 6
  • More info
  • Cite this Item
Item Type
Article
References
If you need an accessible version of this item please contact JSTOR User Support
Central Line–Associated Bloodstream Infection Surveillance outside the Intensive Care Unit: A Multicenter Survey
Preview not available

Abstract

Objective. The success of central line–associated bloodstream infection (CLABSI) prevention programs in intensive care units (ICUs) has led to the expansion of surveillance at many hospitals. We sought to compare non-ICU CLABSI (nCLABSI) rates with national reports and describe methods of surveillance at several participating US institutions.Design and Setting. An electronic survey of several medical centers about infection surveillance practices and rate data for non-ICU patients.Participants. Ten tertiary care hospitals.Methods. In March 2011, a survey was sent to 10 medical centers. The survey consisted of 12 questions regarding demographics and CLABSI surveillance methodology for non-ICU patients at each center. Participants were also asked to provide available rate and device utilization data.Results. Hospitals ranged in size from 238 to 1,400 total beds (median, 815). All hospitals reported using Centers for Disease Control and Prevention (CDC) definitions. Denominators were collected by different means: counting patients with central lines every day (5 hospitals), indirectly estimating on the basis of electronic orders (), or another automated method (). Rates of nCLABSI ranged from 0.2 to 4.2 infections per 1,000 catheter-days (median, 2.5). The national rate reported by the CDC using 2009 data from the National Healthcare Surveillance Network was 1.14 infections per 1,000 catheter-days.Conclusions. Only 2 hospitals were below the pooled CLABSI rate for inpatient wards; all others exceeded this rate. Possible explanations include differences in average central line utilization or hospital size in the impact of certain clinical risk factors notably absent from the definition and in interpretation and reporting practices. Further investigation is necessary to determine whether the national benchmarks are low or whether the hospitals surveyed here represent a selection of outliers.

Page Thumbnails